RocGene (Beijing) Technology Co., Ltd. (hereinafter referred to as Rocgene) was established in 2016 and is a bio-high-tech company founded by scientists and business people and driven by core technology. Rocgene is committed to transforming new technologies in the field of life science research into clinically relevant medical research products, and developing scientific research and molecular diagnostic products with independent intellectual property rights.
RocGene (Beijing) Technology Co., Ltd. is a wholly-owned subsidiary of Rocgene (Beijing) Scientific Instrument Co., Ltd., established in 2019, with more than 10,000 square meters of various plants and supporting facilities that meet national GMP standards. The company has three professional production lines: fluorescence quantitative PCR instrument assembly, fluorescence quantitative PCR diagnostic reagent production, and automatic nucleic acid extraction instrument assembly
National high-tech enterprise
"Specialized, special and new" small and medium-sized enterprises in Beijing
"Innovative" small and medium-sized enterprises in Beijing
Beijing intellectual property pilot unit
Zhongguancun high-tech enterprise
Medical device business license
Medical device production license
Class III medical device product registration certificate
CE-IVD certification qualification